chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 36.0
Sex: M
Vaccine: HEP
Symptoms: Product administered to patient of inappropriate age, Underdose
Clinical narrative: patient was not sure if received the adult or pediatric dose of the Engerix-B but lot number provided was corresponds to a pediatric Engerix-B dose; patient was not sure if received the adult or pediatric dose of the Engerix-B but lot number provided was corresponds to a pediatric Engerix-B dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of underdose in a 36-year-old male patient who received HBV (Engerix B pediatric) (batch number EM9E4, expiry date 17-FEB-2025) for prophylaxis.   On 21-NOV-2023, the patient received Engerix B pediatric. On 21-NOV-2023, an unknown time after receiving Engerix B pediatric, the patient experienced underdose (Verbatim: patient was not sure if received the adult or pediatric dose of the Engerix-B but lot number provided was corresponds to a pediatric Engerix-B dose) and adult use of a child product (Verbatim: patient was not sure if received the adult or pediatric dose of the Engerix-B but lot number provided was corresponds to a pediatric Engerix-B dose). The outcome of the underdose and adult use of a child product were unknown.   Additional Information: GSK Receipt Date: 22-NOV-2023 The pharmacist called to verify a lot number since a patient was not sure if received the adult or pediatric dose of the Engerix-B. The lot number provided was corresponds to a pediatric Engerix-B dose, which led to underdose and adult use of a child product. The HCP (health care professional) asked for guidance on this situation. The reporter consented to follow up.
Sex: U
Vaccine: COVID19
Symptoms: Device issue, No adverse event
Clinical narrative: No adverse event; he did not look but he thinks the plunger went down more than half; This spontaneous case was reported by a pharmacist and describes the occurrence of DEVICE ISSUE (he did not look but he thinks the plunger went down more than half) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) for COVID-19 prophylaxis.    Suspect product included Pre-filled Syringe injection for COVID-19 prophylaxis.    No Medical History information was reported.   On 04-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (unknown route) 1 dosage form. On an unknown date, the patient started Pre-filled Syringe (unknown route) at an unspecified dose. On 04-Oct-2023, after starting mRNA-1273.815 (SPIKEVAX 2023-2024 PFS), the patient experienced DEVICE ISSUE (he did not look but he thinks the plunger went down more than half). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, DEVICE ISSUE (he did not look but he thinks the plunger went down more than half) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for DEVICE ISSUE (he did not look but he thinks the plunger went down more than half).  For Pre-filled Syringe, the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for DEVICE ISSUE (he did not look but he thinks the plunger went down more than half).    No concomitant drug was reported.  Reporter was administering a shot and thinks that the plunger did not go down all the way. He stated that it did not feel right. When asked if there was any liquid in the syringe, reporter stated that he did not look but thinks the plunger went down more than half.  The Device problem code for Spikevax syringe include FDA code 1670, IMDRF code A23 which include Use of Device Problem.  FDA code 4114, IMDRF code B17, method/ type includes Device Not Returned. FDA code 3221, IMDRF code C20, result/findings include No Findings Available.  Operator of Device was pharmacist.  The Spikevax syringe device was malfunctioned, and the type was CIRM.  Rationale for no investigation: This event cannot be further investigated since the consent for the Quality Team to follow up with the complainant was declined. As the batch number was not reported initially and no follow up can be performed, this event will be closed with no investigation.  No treatment drug was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-743106 (E2B Linked Report).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 29-Nov-2023: Significant follow-up received; PQC investigation closed report received.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-743106:Different patient case
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus, Vertigo
Clinical narrative: 4 days following covid booster i noticed ringing in my right ear. This has been ongoing. I had vertigo following my prior covid boosters, this occured within about a week and lasted for about 10 days.
Age: 47.0
Sex: F
Vaccine: TTOX
Symptoms: Fatigue, Headache, Injection site pain, Injection site swelling, Nasal congestion
Clinical narrative: I was due for the tetanus vaccine. The nurse at my doctor's office administered it and let me know the side effects afterwards. I have pain and swelling at the injection site which started several hours after receiving the injection. The next day, it was difficult to move or touch my arm without severe pain. I'm also experiencing a headache, tiredness, and nasal congestion.
Age: 47.0
Sex: F
Vaccine: TTOX
Symptoms: Pain, Tenderness
Clinical narrative: I was due for the tetanus vaccine. The nurse at my doctor's office administered it and let me know the side effects afterwards. I have pain and swelling at the injection site which started several hours after receiving the injection. The next day, it was difficult to move or touch my arm without severe pain. I'm also experiencing a headache, tiredness, and nasal congestion.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Dizziness, Feeling abnormal, Headache
Clinical narrative: On November 7th, I received the Moderna covid vaccine. On Nov 9th, I had severe joint pain, fever, headache, nausea. Covid test was negative. On Nov. 10th, still feeling awful, I tested again. This time I tested positive for covid. On the night of Nov 11th I took my first 4 pill dose of molnupirarvir. About an hour or so after the last dose taken at noon, Nov 16th, I developed a rash which started on my left side, hips to breast, and spread by the next day to my back (hips to neck), right side and abdomen. It was very itchy and red angry looking. It lasted seven days. Then the rash faded but the itch continued a few days. Also on Nov 16th I had swelling of my tongue and mouth. No breathing difficulties. I was light headed from the start of covid through the taking of the medicine. My best guess is that the molnupiravir caused the rash and swelling.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Mouth swelling, Nausea, Pruritus, Pyrexia, Rash
Clinical narrative: On November 7th, I received the Moderna covid vaccine. On Nov 9th, I had severe joint pain, fever, headache, nausea. Covid test was negative. On Nov. 10th, still feeling awful, I tested again. This time I tested positive for covid. On the night of Nov 11th I took my first 4 pill dose of molnupirarvir. About an hour or so after the last dose taken at noon, Nov 16th, I developed a rash which started on my left side, hips to breast, and spread by the next day to my back (hips to neck), right side and abdomen. It was very itchy and red angry looking. It lasted seven days. Then the rash faded but the itch continued a few days. Also on Nov 16th I had swelling of my tongue and mouth. No breathing difficulties. I was light headed from the start of covid through the taking of the medicine. My best guess is that the molnupiravir caused the rash and swelling.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, SARS-CoV-2 test positive, Swollen tongue
Clinical narrative: On November 7th, I received the Moderna covid vaccine. On Nov 9th, I had severe joint pain, fever, headache, nausea. Covid test was negative. On Nov. 10th, still feeling awful, I tested again. This time I tested positive for covid. On the night of Nov 11th I took my first 4 pill dose of molnupirarvir. About an hour or so after the last dose taken at noon, Nov 16th, I developed a rash which started on my left side, hips to breast, and spread by the next day to my back (hips to neck), right side and abdomen. It was very itchy and red angry looking. It lasted seven days. Then the rash faded but the itch continued a few days. Also on Nov 16th I had swelling of my tongue and mouth. No breathing difficulties. I was light headed from the start of covid through the taking of the medicine. My best guess is that the molnupiravir caused the rash and swelling.
Sex: U
Vaccine: TDAP
Symptoms: Muscle atrophy, Muscle swelling, Paraesthesia
Clinical narrative: Right deltoid atrophy with local swelling and paresthesia
Age: 64.0
Sex: F
Vaccine: RSV
Symptoms: Arthralgia, Chills, Dysphagia, Eye swelling, Headache
Clinical narrative: Started with a rash and swelling on right calf, woke up in middle of night with chills, headache, joint pain and itchy.  Over the next two days the rash/hives  spread all over my body, eyes swollen, mouth extremely itchy. Felt like I could no longer swallow dues tot he hives in my mouth. I was taking Benadryl and using anti itch sprays and creams.
Age: 64.0
Sex: F
Vaccine: RSV
Symptoms: Oral pruritus, Pruritus, Rash, Sleep disorder, Swelling
Clinical narrative: Started with a rash and swelling on right calf, woke up in middle of night with chills, headache, joint pain and itchy.  Over the next two days the rash/hives  spread all over my body, eyes swollen, mouth extremely itchy. Felt like I could no longer swallow dues tot he hives in my mouth. I was taking Benadryl and using anti itch sprays and creams.
Age: 64.0
Sex: F
Vaccine: RSV
Symptoms: Urticaria
Clinical narrative: Started with a rash and swelling on right calf, woke up in middle of night with chills, headache, joint pain and itchy.  Over the next two days the rash/hives  spread all over my body, eyes swollen, mouth extremely itchy. Felt like I could no longer swallow dues tot he hives in my mouth. I was taking Benadryl and using anti itch sprays and creams.
Age: 62.0
Sex: M
Vaccine: COVID19-2, FLUC4
Symptoms: Fatigue, Lethargy
Clinical narrative: Patient Given COVID vaccine and flu shot in the same day at his pharmacy.  COVID - Moderna and influenza FLUCELVAX. 2 days later developed significant fatigue and very tired and lethargic, symptoms persisting for over a week, was seen on 11/29/2023 for continued symptoms.
Age: 97.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Swelling face
Clinical narrative: Resident developed severe swelling of  lips and lower face below her cheeks.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, COVID-19, Fibrin D dimer increased, Hypotension, Pulmonary oedema
Clinical narrative: Pt found unresponsive at home, hypotensive: + covid in ED; No shortness of breath and saturating well on 2 L by nasal cannula Tx:  vitamin-C zinc and Lovenox; Elevated D-dimers, CTA of the chest is negative for PE but showed mild pulmonary edema.Discontinue IV fluid, give Lasix.iv.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Unresponsive to stimuli
Clinical narrative: Pt found unresponsive at home, hypotensive: + covid in ED; No shortness of breath and saturating well on 2 L by nasal cannula Tx:  vitamin-C zinc and Lovenox; Elevated D-dimers, CTA of the chest is negative for PE but showed mild pulmonary edema.Discontinue IV fluid, give Lasix.iv.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Aspiration pleural cavity, COVID-19, Chest X-ray abnormal, Dyspnoea, Haemothorax
Clinical narrative: Presented with SOB, + covid 1/25/22;  O2 @ 4 LPM at admission; CXR with L hemithorax; Started on decadron, maxipime,  lovenox; 2/4 thoracentesis and lasix for diuresis; 2/8 down to 1-2 LPM O2; d/c to rehab on room air
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Polyuria, SARS-CoV-2 test positive
Clinical narrative: Presented with SOB, + covid 1/25/22;  O2 @ 4 LPM at admission; CXR with L hemithorax; Started on decadron, maxipime,  lovenox; 2/4 thoracentesis and lasix for diuresis; 2/8 down to 1-2 LPM O2; d/c to rehab on room air
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, COVID-19 pneumonia, Chronic kidney disease, Dehydration, Dyspnoea
Clinical narrative: Presented with SOB,  Dx: Covid pneumonitis; inflammatory markers were very elevated; also had acute kidney injury on CKD stage 3--  likely related to dehydration and poor oral intake.  Id was consulted.  He did not meet any criteria for remdesivir.  He was treated with Lovenox zinc vitamin-C and dexamethasone.  His shortness of breath was significantly improved.  He required 3 L nasal cannula to saturate above 95%.  Home oxygen was arranged.  Ultimately he was discharged to home in a stable condition.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Hypophagia, Inflammatory marker increased
Clinical narrative: Presented with SOB,  Dx: Covid pneumonitis; inflammatory markers were very elevated; also had acute kidney injury on CKD stage 3--  likely related to dehydration and poor oral intake.  Id was consulted.  He did not meet any criteria for remdesivir.  He was treated with Lovenox zinc vitamin-C and dexamethasone.  His shortness of breath was significantly improved.  He required 3 L nasal cannula to saturate above 95%.  Home oxygen was arranged.  Ultimately he was discharged to home in a stable condition.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Dyspnoea, Infection, Pneumonia
Clinical narrative: Patient tested positive for Covid-19 a few days PTA. Patient started to have worsening SOB and came to the ER when his o2 sat was 85%. Patient was diagnosed with acute hypoxic respiratory failure due to pneumonia secondary to Covid-19 infection. Patient received steroids, vitamin supplements, antibiotics, Remdesivir. Patient was discharged home with home o2.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient tested positive for Covid-19 a few days PTA. Patient started to have worsening SOB and came to the ER when his o2 sat was 85%. Patient was diagnosed with acute hypoxic respiratory failure due to pneumonia secondary to Covid-19 infection. Patient received steroids, vitamin supplements, antibiotics, Remdesivir. Patient was discharged home with home o2.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chemotherapy, Colon cancer metastatic, Death, Dyspnoea
Clinical narrative: atient presented to the ER with complaints of worsening shortness of breath. Patient had a recent biliary stent history and was considered to have a very poor prognosis even with chemotherapy due to metastatic colon cancer with mets to liver. Patient was found to be in severe sepsis with multiorgan failure, also tested positive for Covid-19. Detailed discussion was held between MD and daughter, daughter transitioned patient to DNR and comfort care measures only. Patient passed away the next day on 1.1.22
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Metastases to liver, Multiple organ dysfunction syndrome, SARS-CoV-2 test positive, Sepsis, Stent placement
Clinical narrative: atient presented to the ER with complaints of worsening shortness of breath. Patient had a recent biliary stent history and was considered to have a very poor prognosis even with chemotherapy due to metastatic colon cancer with mets to liver. Patient was found to be in severe sepsis with multiorgan failure, also tested positive for Covid-19. Detailed discussion was held between MD and daughter, daughter transitioned patient to DNR and comfort care measures only. Patient passed away the next day on 1.1.22
Age: 72.0
Sex: M
Vaccine: RSV
Symptoms: Diarrhoea, Nausea
Clinical narrative: diarrhea,  uneasy stomach
Age: 72.0
Sex: F
Vaccine: COVID19, FLUA4
Symptoms: Balance disorder, Dizziness, Pruritus, Urticaria, Vertigo
Clinical narrative: 14 days afte the covid/flu shots I got itchy hives.  They swell up if scratched and spread.  I went to the Primary Care PA and was perscribed Cetirizin  and Triamcinolone cream.  14 hours after one dose of the Cetirizine I got terrible vertigo.  3 weeks later, I am still dizzy and a little imbalanced.  I still have the hives and they are not going away.
Age: 71.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: COVID-19, Cough, Decreased appetite, Fatigue, Headache
Clinical narrative: Patient presented to the ER with cough, fatigue, body aches, diminished appetite and headache x 2 weeks. Patient had tested positive for Covid-19 4 days PTA. Patient was treated with steroids, antibiotics, remdesivir and oxygen. Patient was discharged home on home oxygen.
Age: 71.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Pain, SARS-CoV-2 test positive
Clinical narrative: Patient presented to the ER with cough, fatigue, body aches, diminished appetite and headache x 2 weeks. Patient had tested positive for Covid-19 4 days PTA. Patient was treated with steroids, antibiotics, remdesivir and oxygen. Patient was discharged home on home oxygen.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Back pain, COVID-19, COVID-19 pneumonia, Chills
Clinical narrative: Patient presented to the ER with lower back pain with radiation to right leg, abdominal pain, fever, chills, cough and SOB. Patient tested positive for Covid-19 and was diagnosed with covid pneumonia. Patient was treated with Remdesivir. Patient was discharged home.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Pain, Pain in extremity, Pyrexia
Clinical narrative: Patient presented to the ER with lower back pain with radiation to right leg, abdominal pain, fever, chills, cough and SOB. Patient tested positive for Covid-19 and was diagnosed with covid pneumonia. Patient was treated with Remdesivir. Patient was discharged home.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient presented to the ER with lower back pain with radiation to right leg, abdominal pain, fever, chills, cough and SOB. Patient tested positive for Covid-19 and was diagnosed with covid pneumonia. Patient was treated with Remdesivir. Patient was discharged home.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray abnormal, Decreased appetite, Dyspnoea
Clinical narrative: Patient had covid 19 earlier this year (tested positive on January 5). She did not have increased oxygen requirements and was recovering well, tested negative on 1/12. However 7 days prior to admission she began to have decreased appetite, generalized weakness. The day prior to admission she developed SOB, cough productive of yellow phlegm, increasing oxygen requirements, pleuritic pain. In the ER she required 5 LPM NC, covid test is still positive, CXR with bilateral PNA. She was started on antibiotics, steroids and Lovenox. Patient was discharged home with home health.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pleuritic pain, Pneumonia, Productive cough, SARS-CoV-2 test positive, Sputum discoloured
Clinical narrative: Patient had covid 19 earlier this year (tested positive on January 5). She did not have increased oxygen requirements and was recovering well, tested negative on 1/12. However 7 days prior to admission she began to have decreased appetite, generalized weakness. The day prior to admission she developed SOB, cough productive of yellow phlegm, increasing oxygen requirements, pleuritic pain. In the ER she required 5 LPM NC, covid test is still positive, CXR with bilateral PNA. She was started on antibiotics, steroids and Lovenox. Patient was discharged home with home health.
Age: 84.0
Sex: F
Vaccine: FLUA4, RSV
Symptoms: Contusion, Dizziness, Fall, Immediate post-injection reaction
Clinical narrative: Pt felt lightheaded immediately after vaccination. She sat in waiting area for 10 minutes, then walked up the aisle. She crumpled to the ground. Her daughter caught her and helped her down, but she couldn't get back up. Paramedics were called and she was taken to the hospital. They were concerned that she had broken her hip in the fall, but tests showed only bruising. Follow-up call to patient showed she has no lingering effects.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Cough, Dyspnoea
Clinical narrative: Patient presented to the ER with complaints of cough and SOB x 2 days. He tested positive for Covid-19 2 days PTA. Patient diagnosed with acute hypoxic respiratory failure due to Covid-19 pneumonia. Patient was treated with Decadron, vitamin supplements, and oxygen. Patient was successfully weaned off oxygen. Patient was discharged home.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient presented to the ER with complaints of cough and SOB x 2 days. He tested positive for Covid-19 2 days PTA. Patient diagnosed with acute hypoxic respiratory failure due to Covid-19 pneumonia. Patient was treated with Decadron, vitamin supplements, and oxygen. Patient was successfully weaned off oxygen. Patient was discharged home.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Computerised tomogram head normal, Death, Endotracheal intubation
Clinical narrative: Patient was at Rehab and tested positive for Covid-19 on 1.13.22. Patient was admitted to ER after displaying AMS and sudden weakness at Rehab. Patient was started on Levophed and BiPaP at rehab. Patient was transferred to hospital. Patient was intubated on arrival. CT head showed no acute stroke. Patient had received Remdesivir and steroids PTA. Patient placed back on high dose steroids. Patient continued to worsen and made decision to transition patient to comfort care and withdraw life support. Patient passed away 1.29.22.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: General physical health deterioration, Mental status changes, Positive airway pressure therapy, SARS-CoV-2 test positive
Clinical narrative: Patient was at Rehab and tested positive for Covid-19 on 1.13.22. Patient was admitted to ER after displaying AMS and sudden weakness at Rehab. Patient was started on Levophed and BiPaP at rehab. Patient was transferred to hospital. Patient was intubated on arrival. CT head showed no acute stroke. Patient had received Remdesivir and steroids PTA. Patient placed back on high dose steroids. Patient continued to worsen and made decision to transition patient to comfort care and withdraw life support. Patient passed away 1.29.22.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary normal, COVID-19, Lung opacity, Oxygen saturation decreased, Pneumonia
Clinical narrative: Patient presented to the emergency room with the chief complaint of low oxygen saturations. CT angio of the chest showed mild multifocal patchy ground-glass pulmonary opacities, consistent with nonspecific multifocal pneumonia. Patient had a known covid positive test PTA on 1.21.22 from PCP office. Patient received steroids. Patient was discharged home.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient presented to the emergency room with the chief complaint of low oxygen saturations. CT angio of the chest showed mild multifocal patchy ground-glass pulmonary opacities, consistent with nonspecific multifocal pneumonia. Patient had a known covid positive test PTA on 1.21.22 from PCP office. Patient received steroids. Patient was discharged home.
Age: 31.0
Sex: F
Vaccine: COVID19-2
Symptoms: Palpitations
Clinical narrative: Heart palpitations, pretty much all the time but most noticeable when I?m laying down (e.g. trying to fall asleep or just when I?m waking up)
Age: 62.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Loss of personal independence in daily activities, Tremor
Clinical narrative: uncontrolled shaking in arm both vaccine was give(Spikevax and Fluzone). unable to hold a glass of water. advised pt to go to urgent care to be seen.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Nausea, Oxygen saturation decreased, Pyrexia
Clinical narrative: Patient presented to the ER with a 6 day history of fever, nausea and vomiting and SOB.  Patient stated his symptoms began on 11/5 and he tested positive for COVID 11/10.  Patient has managed symptoms at home with over the counter medications but noticed his SOB was getting worse and his oxygen saturations were not recovering. In ER patient noted to be 79% on room air on arrival and required 5L NC to maintain saturations >90%. During hospital stay, oxygen progressively decreased.  He was treated with ceftriaxone and azithromycin daily.  He finished five days of remdesivir therapy in addition to daily or twice daily dexamethasone during hospital stay.  He is now on 2 L NC.  He will be discharged to home with oxyg
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vomiting
Clinical narrative: Patient presented to the ER with a 6 day history of fever, nausea and vomiting and SOB.  Patient stated his symptoms began on 11/5 and he tested positive for COVID 11/10.  Patient has managed symptoms at home with over the counter medications but noticed his SOB was getting worse and his oxygen saturations were not recovering. In ER patient noted to be 79% on room air on arrival and required 5L NC to maintain saturations >90%. During hospital stay, oxygen progressively decreased.  He was treated with ceftriaxone and azithromycin daily.  He finished five days of remdesivir therapy in addition to daily or twice daily dexamethasone during hospital stay.  He is now on 2 L NC.  He will be discharged to home with oxyg
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19 pneumonia, Dyspnoea, Exposure to SARS-CoV-2
Clinical narrative: atient presented to the hospital with shortness of breath and recent COVID exposure.  In the emergency room patient was diagnosed with COVID-19 pneumonia. The patient was started on IV steroid and empiric IV antibiotics.  Her respiratory status was monitored closely.  Initially patient was requiring up to 4-6 L of oxygen via nasal cannula.  Slowly she was weaned down to room air.  She had a prolonged stay in the hospital due to her general debility and multiple other medical comorbidities.  By the time she was discharged she was weaned off steroids and oxygen. She was discharged home with home health care.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Dyspnoea, Hypoxia, Laboratory test normal
Clinical narrative: Patient presented to the ER with complaints of shortness of breath along with low oxygen levels after a recent diagnosis of COVID-19 virus infection. On evaluation in the ED, workup revealed unremarkable labs but imaging significant for multifocal pneumonia. The patient was diagnosed with COVID pneumonia with hypoxia. Patient received IV abx, steroids, and Remdesivir. Patient showed improvement and was discharged home.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Pulmonary imaging procedure abnormal
Clinical narrative: Patient presented to the ER with complaints of shortness of breath along with low oxygen levels after a recent diagnosis of COVID-19 virus infection. On evaluation in the ED, workup revealed unremarkable labs but imaging significant for multifocal pneumonia. The patient was diagnosed with COVID pneumonia with hypoxia. Patient received IV abx, steroids, and Remdesivir. Patient showed improvement and was discharged home.
Age: 0.58
Sex: F
Vaccine: FLU4
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: The patient received her first influenza vaccine on 11/4/23 and was scheduled by the staff to come back 10 days later for her 2nd dose, not 4 weeks later so she received the 2nd dose too soon. She had no adverse reactions from the second dose.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Ascites, COVID-19, Computerised tomogram abdomen abnormal, Dyspnoea exertional, Hepatic mass
Clinical narrative: Patient presented with complaints of exertional shortness of breath along with bilateral lower extremity swelling. T scan of the abdomen and pelvis showed diffuse nodular and fatty infiltration of the liver consistent with steatohepatitis along with moderate ascites that raises question of portal hypertension.  Abdominal Ultrasound showed very dense fatty infiltration of the liver, nodular liver, appearance consistent with steatohepatitis with possible cirrhosis along with moderate ascites.  Patient also tested positive for COVID-19. Patient received Rocephin and Azithromycin. Patient was discharged to SNU
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Hepatic steatosis, Peripheral swelling, SARS-CoV-2 test positive, Steatohepatitis, Ultrasound abdomen abnormal
Clinical narrative: Patient presented with complaints of exertional shortness of breath along with bilateral lower extremity swelling. T scan of the abdomen and pelvis showed diffuse nodular and fatty infiltration of the liver consistent with steatohepatitis along with moderate ascites that raises question of portal hypertension.  Abdominal Ultrasound showed very dense fatty infiltration of the liver, nodular liver, appearance consistent with steatohepatitis with possible cirrhosis along with moderate ascites.  Patient also tested positive for COVID-19. Patient received Rocephin and Azithromycin. Patient was discharged to SNU
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Migraine, Pain, Pyrexia
Clinical narrative: Severe upper back pain, migraine, 100.8 F fever, moderate to severe body aches and joint pain. All took place about 18 hours after injection
Age: 84.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Peripheral swelling
Clinical narrative: Large amount of swelling in the arm that recieved both vaccines. Advised pt follow up with PCP.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Fibrin D dimer
Clinical narrative: Patient presented to the ER with recent diagnosis of Covid-19 infection. Patient diagnosed with acute respiratory failure requiring 2L oxygen. D-dimer 8.53. Patient was started on Azithromycin, Ceftriaxone, Dexamethasone, vitamin supplements. Timeline was not in favor of initiating Remdesivir. Patient was transferred to an acute hospital.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Atrial fibrillation, Back pain, COVID-19, Dehydration, Malaise
Clinical narrative: Admit date: 11/22/2023  Discharge date: 11/27/2023  Admitting Physician: DO   Attending Physician at the Time of Discharge: DO  Reason for Admission: Syncope and collapse secondary to vasovagal from dehydration due to COVID found to have T7, T9, T11 vertebral body fractures, as well as Rib 6 and Rib 7 fracture   Brief Summary of Hospital Stay: Patient is a 71 YO year old female with past medical history of RLL adenocarcinoma of lung s/p radiation therapy, seizure disorder, asthma, arthritis, HTN presenting to Hospital with complaint of syncope, collapse and back pain. Found to have multiple rib fractures, as well as multiple thoracic vertebral body fractures. Also found with new onset afib RVR.  Hospital Course:  Patient completed 5 days of remdesivir, with significant improvement in covid symptoms. She remained stable on RA. Neurosurgery was consulted for her multiple vertebral compression fractures, and patient was given a TLSO brace. For her Afib RVR she was placed on heparing gtt for 24 hours and transitioned to Eliquis  Upon exam this morning, patient feeling overall better. Endorses pain is controlled. Patient was medically optimized. Vital signs were stable for discharge. Discharged to home.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Orthosis user, Pain, Rib fracture, Spinal compression fracture, Syncope
Clinical narrative: Admit date: 11/22/2023  Discharge date: 11/27/2023  Admitting Physician: DO   Attending Physician at the Time of Discharge: DO  Reason for Admission: Syncope and collapse secondary to vasovagal from dehydration due to COVID found to have T7, T9, T11 vertebral body fractures, as well as Rib 6 and Rib 7 fracture   Brief Summary of Hospital Stay: Patient is a 71 YO year old female with past medical history of RLL adenocarcinoma of lung s/p radiation therapy, seizure disorder, asthma, arthritis, HTN presenting to Hospital with complaint of syncope, collapse and back pain. Found to have multiple rib fractures, as well as multiple thoracic vertebral body fractures. Also found with new onset afib RVR.  Hospital Course:  Patient completed 5 days of remdesivir, with significant improvement in covid symptoms. She remained stable on RA. Neurosurgery was consulted for her multiple vertebral compression fractures, and patient was given a TLSO brace. For her Afib RVR she was placed on heparing gtt for 24 hours and transitioned to Eliquis  Upon exam this morning, patient feeling overall better. Endorses pain is controlled. Patient was medically optimized. Vital signs were stable for discharge. Discharged to home.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Thoracic vertebral fracture
Clinical narrative: Admit date: 11/22/2023  Discharge date: 11/27/2023  Admitting Physician: DO   Attending Physician at the Time of Discharge: DO  Reason for Admission: Syncope and collapse secondary to vasovagal from dehydration due to COVID found to have T7, T9, T11 vertebral body fractures, as well as Rib 6 and Rib 7 fracture   Brief Summary of Hospital Stay: Patient is a 71 YO year old female with past medical history of RLL adenocarcinoma of lung s/p radiation therapy, seizure disorder, asthma, arthritis, HTN presenting to Hospital with complaint of syncope, collapse and back pain. Found to have multiple rib fractures, as well as multiple thoracic vertebral body fractures. Also found with new onset afib RVR.  Hospital Course:  Patient completed 5 days of remdesivir, with significant improvement in covid symptoms. She remained stable on RA. Neurosurgery was consulted for her multiple vertebral compression fractures, and patient was given a TLSO brace. For her Afib RVR she was placed on heparing gtt for 24 hours and transitioned to Eliquis  Upon exam this morning, patient feeling overall better. Endorses pain is controlled. Patient was medically optimized. Vital signs were stable for discharge. Discharged to home.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, COVID-19, Renal impairment, SARS-CoV-2 test positive
Clinical narrative: Patient was sent over from NH due to acutely worsened renal function. Patient was Covid positive. Patient was diagnosed with acute kidney injury and acute hypoxemic respiratory failure multifactorial from AKI, and recent COVID 19. Patient received IV antibiotics and steroids. Patient was unable to receive Remdesivir as he was out of the timeframe and had an AKI. Patient was discharged back to nursing home.
Age: 32.0
Sex: M
Vaccine: FLUC4
Symptoms: Arthralgia, Pain, Pain in extremity
Clinical narrative: Soreness in right arm the day following the injection that developed into sharp pain in shoulder whenever moving arm farther than a few inches specifically when reaching up or across body.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, COVID-19, Cardiac failure acute, Cardiac failure congestive, Cardio-respiratory arrest
Clinical narrative: Patient presented to clinic with SOB, onset 2-3 weeks PTA, worsening over time. Dypsnea at rest and worse with exertion. Patient diagnosed with covid-19 infection and pneumonia, AKI, acute on chronic CHF, anasarca. Kidney function worsened so patient was transferred to hospital on 1.13.22 for CRRT. On arrival to hospital, patient coded and was pronounced.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Dyspnoea at rest, Dyspnoea exertional, Generalised oedema, Pneumonia
Clinical narrative: Patient presented to clinic with SOB, onset 2-3 weeks PTA, worsening over time. Dypsnea at rest and worse with exertion. Patient diagnosed with covid-19 infection and pneumonia, AKI, acute on chronic CHF, anasarca. Kidney function worsened so patient was transferred to hospital on 1.13.22 for CRRT. On arrival to hospital, patient coded and was pronounced.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Renal impairment
Clinical narrative: Patient presented to clinic with SOB, onset 2-3 weeks PTA, worsening over time. Dypsnea at rest and worse with exertion. Patient diagnosed with covid-19 infection and pneumonia, AKI, acute on chronic CHF, anasarca. Kidney function worsened so patient was transferred to hospital on 1.13.22 for CRRT. On arrival to hospital, patient coded and was pronounced.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Atelectasis, COVID-19, Cardiomegaly, Chest X-ray abnormal, Chronic obstructive pulmonary disease
Clinical narrative: Admit date: 11/26/2023  Discharge date: 11/27/2023  Admitting Physician:  MD   Attending Physician at the Time of Discharge: Dr.   Reason for Admission: Concern for LE infection    Hospital Course: Patient is a 71 year old male with PMHx of COPD, centrilobular emphysema, lung carcinoma (s/p resection 2012), T1DM, HFrEF (last EF ~40%), third degree AV block s/p AICD 2019, HTN, Graves disease, and BPH presenting to the ED on 11/26/23 with chief complaint of fever and headache.   Patient had subjective fever at home and was concerned his right leg was becoming infected again. Vitals on arrival: Temp 101.1, BP 154/100, HR 80, RR 18, SPO2 94% on room air. On arrival, labs unremarkable but positive for COVID-19. Right leg venous duplex US was negative for DVT. CT right leg showed diffuse subcutaneous edema, no gas or abscess. CXR showed moderate cardiomegaly, mild pulmonary vascular distention, mild COPD, and linear atelectasis of right lung base. Patient was started on ceftriaxone and vancomycin, but there is no concern for sepsis or cellulitis at this time and were discontinued.  Patient was assessed by Wound Care team who noted left and right lower leg intact scabs and no interventions were necessary at this time.  Patient should continue following up with outpatient wound care. Discharged to home.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram abnormal, Computerised tomogram limb, Condition aggravated, Headache, Laboratory test normal
Clinical narrative: Admit date: 11/26/2023  Discharge date: 11/27/2023  Admitting Physician:  MD   Attending Physician at the Time of Discharge: Dr.   Reason for Admission: Concern for LE infection    Hospital Course: Patient is a 71 year old male with PMHx of COPD, centrilobular emphysema, lung carcinoma (s/p resection 2012), T1DM, HFrEF (last EF ~40%), third degree AV block s/p AICD 2019, HTN, Graves disease, and BPH presenting to the ED on 11/26/23 with chief complaint of fever and headache.   Patient had subjective fever at home and was concerned his right leg was becoming infected again. Vitals on arrival: Temp 101.1, BP 154/100, HR 80, RR 18, SPO2 94% on room air. On arrival, labs unremarkable but positive for COVID-19. Right leg venous duplex US was negative for DVT. CT right leg showed diffuse subcutaneous edema, no gas or abscess. CXR showed moderate cardiomegaly, mild pulmonary vascular distention, mild COPD, and linear atelectasis of right lung base. Patient was started on ceftriaxone and vancomycin, but there is no concern for sepsis or cellulitis at this time and were discontinued.  Patient was assessed by Wound Care team who noted left and right lower leg intact scabs and no interventions were necessary at this time.  Patient should continue following up with outpatient wound care. Discharged to home.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Localised infection, Oedema peripheral, Pulmonary vascular disorder, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Admit date: 11/26/2023  Discharge date: 11/27/2023  Admitting Physician:  MD   Attending Physician at the Time of Discharge: Dr.   Reason for Admission: Concern for LE infection    Hospital Course: Patient is a 71 year old male with PMHx of COPD, centrilobular emphysema, lung carcinoma (s/p resection 2012), T1DM, HFrEF (last EF ~40%), third degree AV block s/p AICD 2019, HTN, Graves disease, and BPH presenting to the ED on 11/26/23 with chief complaint of fever and headache.   Patient had subjective fever at home and was concerned his right leg was becoming infected again. Vitals on arrival: Temp 101.1, BP 154/100, HR 80, RR 18, SPO2 94% on room air. On arrival, labs unremarkable but positive for COVID-19. Right leg venous duplex US was negative for DVT. CT right leg showed diffuse subcutaneous edema, no gas or abscess. CXR showed moderate cardiomegaly, mild pulmonary vascular distention, mild COPD, and linear atelectasis of right lung base. Patient was started on ceftriaxone and vancomycin, but there is no concern for sepsis or cellulitis at this time and were discontinued.  Patient was assessed by Wound Care team who noted left and right lower leg intact scabs and no interventions were necessary at this time.  Patient should continue following up with outpatient wound care. Discharged to home.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Scab, Ultrasound Doppler normal
Clinical narrative: Admit date: 11/26/2023  Discharge date: 11/27/2023  Admitting Physician:  MD   Attending Physician at the Time of Discharge: Dr.   Reason for Admission: Concern for LE infection    Hospital Course: Patient is a 71 year old male with PMHx of COPD, centrilobular emphysema, lung carcinoma (s/p resection 2012), T1DM, HFrEF (last EF ~40%), third degree AV block s/p AICD 2019, HTN, Graves disease, and BPH presenting to the ED on 11/26/23 with chief complaint of fever and headache.   Patient had subjective fever at home and was concerned his right leg was becoming infected again. Vitals on arrival: Temp 101.1, BP 154/100, HR 80, RR 18, SPO2 94% on room air. On arrival, labs unremarkable but positive for COVID-19. Right leg venous duplex US was negative for DVT. CT right leg showed diffuse subcutaneous edema, no gas or abscess. CXR showed moderate cardiomegaly, mild pulmonary vascular distention, mild COPD, and linear atelectasis of right lung base. Patient was started on ceftriaxone and vancomycin, but there is no concern for sepsis or cellulitis at this time and were discontinued.  Patient was assessed by Wound Care team who noted left and right lower leg intact scabs and no interventions were necessary at this time.  Patient should continue following up with outpatient wound care. Discharged to home.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood lactic acid, COVID-19, Computerised tomogram abdomen abnormal, Dehydration
Clinical narrative: atient presented to emergency department for evaluation of nausea, vomiting and weakness.  He was treated for urinary tract infection as outpatient with nitrofurantoin.  When he presented emergency department he was febrile and met criteria for systemic inflammatory response syndrome with a lactic acid level of 2.39.  Was initiated on aggressive fluid resuscitation with good response.  Patient tested positive for COVID-19. Patient had vomiting and diarrhea which was suspicious for enteritis.  CT of the abdomen pelvis revealed enteritis and likely could be secondary to COVID-19. Most likely patient had severe sepsis in the setting of COVID-19. Patient had acute metabolic encephalopathy in the setting of COVID-19 and dehydration.  He has underlying dementia.  Patient mental status improved but patient continues to have waxing and waning delirium at times. Patient was discharged home with prior home health service.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Delirium, Diarrhoea, Enteritis, Mental status changes, Metabolic encephalopathy
Clinical narrative: atient presented to emergency department for evaluation of nausea, vomiting and weakness.  He was treated for urinary tract infection as outpatient with nitrofurantoin.  When he presented emergency department he was febrile and met criteria for systemic inflammatory response syndrome with a lactic acid level of 2.39.  Was initiated on aggressive fluid resuscitation with good response.  Patient tested positive for COVID-19. Patient had vomiting and diarrhea which was suspicious for enteritis.  CT of the abdomen pelvis revealed enteritis and likely could be secondary to COVID-19. Most likely patient had severe sepsis in the setting of COVID-19. Patient had acute metabolic encephalopathy in the setting of COVID-19 and dehydration.  He has underlying dementia.  Patient mental status improved but patient continues to have waxing and waning delirium at times. Patient was discharged home with prior home health service.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, SARS-CoV-2 test positive, Sepsis, Systemic inflammatory response syndrome
Clinical narrative: atient presented to emergency department for evaluation of nausea, vomiting and weakness.  He was treated for urinary tract infection as outpatient with nitrofurantoin.  When he presented emergency department he was febrile and met criteria for systemic inflammatory response syndrome with a lactic acid level of 2.39.  Was initiated on aggressive fluid resuscitation with good response.  Patient tested positive for COVID-19. Patient had vomiting and diarrhea which was suspicious for enteritis.  CT of the abdomen pelvis revealed enteritis and likely could be secondary to COVID-19. Most likely patient had severe sepsis in the setting of COVID-19. Patient had acute metabolic encephalopathy in the setting of COVID-19 and dehydration.  He has underlying dementia.  Patient mental status improved but patient continues to have waxing and waning delirium at times. Patient was discharged home with prior home health service.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Urinary tract infection, Vomiting
Clinical narrative: atient presented to emergency department for evaluation of nausea, vomiting and weakness.  He was treated for urinary tract infection as outpatient with nitrofurantoin.  When he presented emergency department he was febrile and met criteria for systemic inflammatory response syndrome with a lactic acid level of 2.39.  Was initiated on aggressive fluid resuscitation with good response.  Patient tested positive for COVID-19. Patient had vomiting and diarrhea which was suspicious for enteritis.  CT of the abdomen pelvis revealed enteritis and likely could be secondary to COVID-19. Most likely patient had severe sepsis in the setting of COVID-19. Patient had acute metabolic encephalopathy in the setting of COVID-19 and dehydration.  He has underlying dementia.  Patient mental status improved but patient continues to have waxing and waning delirium at times. Patient was discharged home with prior home health service.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, COVID-19, Chest pain, Electrocardiogram ST segment elevation, Pain
Clinical narrative: Patient presents emergency department with complaints of chest pain that started 1 hour prior to arrival.  Patient reported pain as being constant and severe radiating to the right arm and right side of the chest.  On arrival to the ED showed sinus tachycardia with ST elevation in leads V2 to be 5. STEMI was activated. Patient was also found to be covid positive. Patient was admitted for a STEMI with clinical course complicated by Covid-19. Patient had a PCI done of LCX. Patient was discharged home.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Percutaneous coronary intervention, SARS-CoV-2 test positive, Sinus tachycardia
Clinical narrative: Patient presents emergency department with complaints of chest pain that started 1 hour prior to arrival.  Patient reported pain as being constant and severe radiating to the right arm and right side of the chest.  On arrival to the ED showed sinus tachycardia with ST elevation in leads V2 to be 5. STEMI was activated. Patient was also found to be covid positive. Patient was admitted for a STEMI with clinical course complicated by Covid-19. Patient had a PCI done of LCX. Patient was discharged home.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Pyrexia, Vomiting
Clinical narrative: ~ 3 hours after receipt started a sore arm, low grade fever, nausea vomiting (this did not resolve for a full 48 hours)  - He also had a sore arm (gestured to his left arm)  - Completely resolved on its own, no lasting issues